Nevertheless, these data suggest that targeting leptin/OB-R functions may negatively impact tumor growth, angiogenesis, apoptosis, and expression of inflammation-related factors and could impair leptin-growth promoter-factor crosstalk in human BC. The gene discussed is LEP; the disease is breast cancer.